Giulia Orsi

1.1k total citations
34 papers, 514 citations indexed

About

Giulia Orsi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Giulia Orsi has authored 34 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 12 papers in Cancer Research. Recurrent topics in Giulia Orsi's work include Pancreatic and Hepatic Oncology Research (13 papers), Renal cell carcinoma treatment (8 papers) and Cancer Genomics and Diagnostics (8 papers). Giulia Orsi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (13 papers), Renal cell carcinoma treatment (8 papers) and Cancer Genomics and Diagnostics (8 papers). Giulia Orsi collaborates with scholars based in Italy, United States and United Kingdom. Giulia Orsi's co-authors include Stefano Cascinu, Andrea Casadei‐Gardini, Giulia Rovesti, Massimo Dominici, Michele Reni, Carlotta Spano, Marina Macchini, Alessandra Recchia, Edwin M. Horwitz and Francesco Catanzariti and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Hepatology and Annals of Oncology.

In The Last Decade

Giulia Orsi

33 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giulia Orsi Italy 12 220 171 148 115 113 34 514
Nina Waldburger Germany 13 149 0.7× 201 1.2× 94 0.6× 73 0.6× 119 1.1× 19 456
T. Macarulla Mercadé Spain 12 296 1.3× 147 0.9× 128 0.9× 148 1.3× 68 0.6× 60 459
Ruoyu Shi China 5 256 1.2× 142 0.8× 67 0.5× 86 0.7× 201 1.8× 15 473
A. Reinacher-Schick Germany 11 441 2.0× 175 1.0× 146 1.0× 93 0.8× 149 1.3× 46 636
Imane El Dika United States 13 214 1.0× 207 1.2× 109 0.7× 81 0.7× 145 1.3× 30 573
Ji Hyun Lee South Korea 12 269 1.2× 282 1.6× 232 1.6× 45 0.4× 80 0.7× 23 609
Tae Sung Ahn South Korea 15 294 1.3× 255 1.5× 119 0.8× 68 0.6× 105 0.9× 45 602
Richard Ong Singapore 9 116 0.5× 207 1.2× 110 0.7× 52 0.5× 84 0.7× 20 413
Minsig Choi United States 14 360 1.6× 190 1.1× 134 0.9× 82 0.7× 104 0.9× 28 549
Fangchao Zheng China 9 425 1.9× 272 1.6× 278 1.9× 130 1.1× 203 1.8× 33 800

Countries citing papers authored by Giulia Orsi

Since Specialization
Citations

This map shows the geographic impact of Giulia Orsi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Orsi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Orsi more than expected).

Fields of papers citing papers by Giulia Orsi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Orsi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Orsi. The network helps show where Giulia Orsi may publish in the future.

Co-authorship network of co-authors of Giulia Orsi

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Orsi. A scholar is included among the top collaborators of Giulia Orsi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Orsi. Giulia Orsi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Orsi, Giulia, et al.. (2024). Isolated lung metastases from pancreatic ductal adenocarcinoma (PDAC): Diagnostic and therapeutic challenges of a different disease. Seminars in Oncology. 51(3-4). 69–76. 3 indexed citations
2.
Vanella, Giuseppe, Giuseppe Dell’Anna, Gabriele Capurso, et al.. (2023). EUS-guided gastroenterostomy for management of malignant gastric outlet obstruction: a prospective cohort study with matched comparison with enteral stenting. Gastrointestinal Endoscopy. 98(3). 337–347.e5. 39 indexed citations
3.
Petrelli, Fausto, Michele Ghidini, Marina Macchini, et al.. (2023). The Role of Neoadjuvant FOLFIRINOX in Borderline Resectable Pancreatic Cancer: A Network Meta-Analysis. Journal of Gastrointestinal Cancer. 54(4). 1376–1379. 1 indexed citations
4.
Gasparini, Giulia, Francesca Aleotti, Giulio Belfiori, et al.. (2023). The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma. Digestive and Liver Disease. 55(12). 1750–1756. 4 indexed citations
5.
Vivaldi, Caterina, Clara Ugolini, Andrea Casadei‐Gardini, et al.. (2023). Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology. Oncology. 102(2). 157–167. 4 indexed citations
6.
Grassini, Greta, Lorenza Pecciarini, Marco Schiavo Lena, et al.. (2022). Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples. Clinical Gastroenterology and Hepatology. 21(11). 2825–2833. 9 indexed citations
7.
Macchini, Marina, Umberto Peretti, Giulia Orsi, et al.. (2022). Epidemiology and geographic distribution of BRCA1-2 and DNA Damage response genes pathogenic variants in pancreatic ductal adenocarcinoma patients. Cancer Treatment Reviews. 104. 102357–102357. 3 indexed citations
8.
Casadei‐Gardini, Andrea, Sara Lonardi, Valeria Smiroldo, et al.. (2021). Extensive molecular reclassification: new perspectives in small bowel adenocarcinoma?. Medical Oncology. 38(2). 17–17. 1 indexed citations
9.
Macchini, Marina, Umberto Peretti, Giulia Orsi, et al.. (2020). Exploring chemotherapy holiday and drugs re-challenge in advanced pancreatic cancer patients. Cancer Chemotherapy and Pharmacology. 87(1). 95–101. 2 indexed citations
10.
Reni, Michele, Umberto Peretti, Silvia Zanon, et al.. (2020). Time to CA19-9 nadir: a clue for defining optimal treatment duration in patients with resectable pancreatic ductal adenocarcinoma. Cancer Chemotherapy and Pharmacology. 85(4). 641–650. 9 indexed citations
11.
Casadei‐Gardini, Andrea, Fabio Gelsomino, Andrea Spallanzani, et al.. (2020). Is There an Optimal Choice in Refractory Colorectal Cancer? A Network Meta-Analysis. Clinical Colorectal Cancer. 19(2). 82–90.e9. 9 indexed citations
12.
Rovesti, Giulia, Giulia Orsi, Luca Faloppi, et al.. (2019). Sorafenib in patients with hepatocellular carcinoma: 10 years of real life. Annals of Oncology. 30. iv57–iv57. 1 indexed citations
13.
Tovoli, Francesco, Luca Ielasi, Andrea Casadei‐Gardini, et al.. (2019). Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients. Journal of Hepatology. 71(6). 1175–1183. 61 indexed citations
14.
Marisi, Giorgia, Vincenzo Dadduzio, Luca Ielasi, et al.. (2019). Multicentric prospective study of validation of angiogenesis-related gene polymorphisms in hepatocellular carcinoma patients treated with sorafenib: results of INNOVATE study. Annals of Oncology. 30. iv113–iv113. 1 indexed citations
15.
Rossignoli, Filippo, Carlotta Spano, Giulia Grisendi, et al.. (2019). MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic Adenocarcinoma. Theranostics. 9(2). 436–448. 43 indexed citations
16.
Salati, Massimiliano, Giulia Orsi, Giordano Beretta, et al.. (2019). Gastric cancer: Translating novels concepts into clinical practice. Cancer Treatment Reviews. 79. 101889–101889. 58 indexed citations
17.
Tomasello, Chiara, Cinzia Baldessari, Giulia Orsi, et al.. (2018). Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives. Critical Reviews in Oncology/Hematology. 123. 149–161. 49 indexed citations
18.
Gelsomino, Fabio, et al.. (2018). To resect or not to resect: The hamletic dilemma of primary tumor resection in patients with asymptomatic stage IV colorectal cancer. Critical Reviews in Oncology/Hematology. 132. 154–160. 6 indexed citations
19.
Rossignoli, Filippo, Giulia Grisendi, Carlotta Spano, et al.. (2018). Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy. Cancer Gene Therapy. 26(1-2). 11–16. 49 indexed citations
20.
Salati, Massimiliano, Giulia Orsi, Luca Reggiani Bonetti, et al.. (2017). Heavily calcified gastrointestinal stromal tumors: Pathophysiology and implications of a rare clinicopathologic entity. World Journal of Gastrointestinal Oncology. 9(3). 135–135. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nina Waldburger Breakdown of academic impact, for papers by T. Macarulla Mercadé Breakdown of academic impact, for papers by Ruoyu Shi Breakdown of academic impact, for papers by A. Reinacher-Schick Breakdown of academic impact, for papers by Imane El Dika Breakdown of academic impact, for papers by Ji Hyun Lee Breakdown of academic impact, for papers by Tae Sung Ahn Breakdown of academic impact, for papers by Richard Ong Breakdown of academic impact, for papers by Minsig Choi Breakdown of academic impact, for papers by Fangchao Zheng
Rankless by CCL
2026